Real world effectiveness of sotrovimab in preventing COVID-19-related hospitalisation or death in patients infected with Omicron BA.2

• Main Authors: Alwaleed Behzad (Author), Aamal Mohamed (Author), Ahmed Ali (Author), Sara Niinuma (Author), Alexandra E. Butler (Author), Manaf Alqahtani (Author)
• Format: Bog
• Udgivet: Elsevier, 2024-02-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

Background: Laboratory-based evidence indicates that neutralization of the BA.2 (Omicron) variant by sotrovimab is reduced versus previous SARS-CoV-2 variants. Since there is a lack of real-world data, we investigated whether sotrovimab has reduced clinical efficacy against the BA.2 variant. Methods...